Cannabinoid Encyclopedia

What the body does with compounds

What does Pharmacokinetics mean?

How a compound is absorbed, distributed, metabolized, and eliminated. 1

Simple definition

Pharmacokinetics, in plain English

How a compound is absorbed, distributed, metabolized, and eliminated. 1

Why it matters

How this word is used in cannabinoid research

This word helps explain what happens to a compound in the body or what the compound does at a biological target.

How to read it

Read the definition beside the study details, including dose, route, product, population, and outcome.

Common questions

Questions people ask

What does Pharmacokinetics mean?

How a compound is absorbed, distributed, metabolized, and eliminated.

Why does Pharmacokinetics matter?

This word helps explain what happens to a compound in the body or what the compound does at a biological target.

Is Pharmacokinetics proof that a cannabinoid works?

No. A definition helps explain the language. The related research pages and their sources show what was actually studied.

Sources

Research connected to this term

Definitions explain the word. These links show research records currently connected with it.

  1. 1
    A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats preclinical PubMed 39528623
  2. 2
    Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial. preliminary human PubMed 38797087
  3. 3
    A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. mechanistic or pharmacological PubMed 30374683
  4. 4
    Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding. insufficient PubMed 35903331
  5. 5
    Physiological effect and pharmacokinetic evaluation of combined oral administration of cannabidiolic acid and cannabigerolic acid in dogs. mechanistic or pharmacological PubMed 41822224
  6. 6
    Cannabis use during pregnancy: Pharmacokinetics and effects on child development. insufficient PubMed 28847562
See all 16 connected research sources
  1. 1
    A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats preclinical PubMed 39528623
  2. 2
    Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial. preliminary human PubMed 38797087
  3. 3
    A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. mechanistic or pharmacological PubMed 30374683
  4. 4
    Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding. insufficient PubMed 35903331
  5. 5
    Physiological effect and pharmacokinetic evaluation of combined oral administration of cannabidiolic acid and cannabigerolic acid in dogs. mechanistic or pharmacological PubMed 41822224
  6. 6
    Cannabis use during pregnancy: Pharmacokinetics and effects on child development. insufficient PubMed 28847562
  7. 7
    A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment. insufficient PubMed 31802404
  8. 8
    Pharmacokinetics and pharmacodynamics of cannabinoids. insufficient PubMed 12648025
  9. 9
    Pharmacokinetics of Non-Psychotropic Phytocannabinoids. insufficient PubMed 40006604
  10. 10
    Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats. preclinical PubMed 40643195
  11. 11
    Physiologically based pharmacokinetic modeling and simulation of cannabinoids in human plasma and tissues. mechanistic or pharmacological PubMed 36272108
  12. 12
    Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation. mechanistic or pharmacological PubMed 35246858
  13. 13
    Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs. mechanistic or pharmacological PubMed 33134364
  14. 14
    Computational Analysis of Dipyrone Metabolite 4-Aminoantipyrine As A Cannabinoid Receptor 1 Agonist. insufficient PubMed 31490743
  15. 15
    The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels. preclinical PubMed 40465624
  16. 16
    Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification. insufficient PubMed 26839710